Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “The United States of America, as represented by the Secretary, Department of Health and Human”

1,164 pharma patents match "The United States of America, as represented by the Secretary, Department of Health and Human" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 1,164
Index total 30,257
Page 36 / 49

Quick answer

This filtered view shows 1,164 pharmaceutical patents matching "The United States of America, as represented by the Secretary, Department of Health and Human" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

1,164 results for “The United States of America, as represented by the Secretary, Department of Health and Human” · 30,257 patents in full index Clear search

  1. US 9243036

    Anti-microbial activity of synthetic peptides

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 26, 2016 · Expires Jan 21, 2036

    granted

  2. US 9238684

    SPANX-B polypeptides and their use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 19, 2016 · Expires Jan 14, 2036

    granted

  3. US 9238069

    Method of sensitizing cancer cells to the cytotoxic effects of death receptor ligands in cancer treatment

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 19, 2016 · Expires Jan 14, 2036

    granted

  4. US 9238799

    Antigenic chimeric tick-borne encephalitis virus/dengue virus type 4 recombinant viruses

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 19, 2016 · Expires Jan 14, 2036

    granted

  5. US 9238800

    Avian adenoassociated virus and uses thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 19, 2016 · Expires Jan 14, 2036

    granted

  6. US 9233973

    Pharmaceutical compositions which inhibit FKBP52-mediated regulation of androgen receptor function and methods of using same

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 12, 2016 · Expires Jan 7, 2036

    granted

  7. US 9228171

    Regulatory B cells (tBREGS) and their use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 5, 2016 · Expires Dec 31, 2035

    granted

  8. US 9222086

    Compositions and methods for silencing genes expressed in cancer

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 29, 2015 · Expires Dec 24, 2035

    granted

  9. US 9211302

    Modulation of LRCH4 activity and therapeutic application thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 15, 2015 · Expires Dec 10, 2035

    granted

  10. US 9206154

    Inverse agonists and neutral antagonists for the TSH receptor

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 8, 2015 · Expires Dec 3, 2035

    granted

  11. US 9205091

    Diazeniumdiolated compounds, pharmaceutical compositions, and method of treating cancer

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 8, 2015 · Expires Dec 3, 2035

    granted

  12. US 9206257

    Human monoclonal antibodies specific for glypican-3 and use thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 8, 2015 · Expires Dec 3, 2035

    granted

  13. US 9206245

    Immunogenic peptides and methods of use for treating and preventing cancer

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 8, 2015 · Expires Dec 3, 2035

    granted

  14. US 9198976

    Polysaccharide-protein conjugate vaccines

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 1, 2015 · Expires Nov 26, 2035

    granted

  15. US 9193769

    Bovine adeno-associated viral (BAAV) vector and uses thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 24, 2015 · Expires Nov 19, 2035

    granted

  16. US 9193790

    Use of antagonists of the interaction between HIV GP120 and A4B7 integrin

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 24, 2015 · Expires Nov 19, 2035

    granted

  17. US 9186365

    Antiangiogenic small molecules and methods of use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 17, 2015 · Expires Nov 12, 2035

    granted

  18. US 9186406

    Compositions containing nucleosides and manganese and their uses

    THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, OFFICE OF TECHNOLOGY TRANSFER—NATIONAL INSTITUTES OF HEALTH · Granted Nov 17, 2015 · Expires Nov 12, 2035

    granted

  19. US 9180133

    Method for treating uterine fibroids

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 10, 2015 · Expires Nov 5, 2035

    granted

  20. US 9181340

    TEM8 antibodies, conjugates thereof, and their use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 10, 2015 · Expires Nov 5, 2035

    granted

  21. US 9181253

    Adenosine receptor agonists, partial agonists, and antagonists

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 10, 2015 · Expires Nov 5, 2035

    granted

  22. US 9181306

    Insertion of foreign genes in rubella virus and their stable expression in a live, attenuated viral vaccine

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 10, 2015 · Expires Nov 5, 2035

    granted

  23. US 9181327

    Anti-HIV domain antibodies and method of making and using same

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 10, 2015 · Expires Nov 5, 2035

    granted

  24. US 9181530

    Infectious hepatitis E virus genotype 3 recombinants

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 10, 2015 · Expires Nov 5, 2035

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.